Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer ' s Begin

A subsidiary of Core One Labs CLABF has signed a contract with Fundació Bosh I Gimpera to begin second-phase studies evaluating the therapeutic potential of its bio-compounds (both alone and combined with psychedelic substances). The studies would progress Akome Partners’ pre-clinical development…#coreonelabsclabf #fundacióboshigimpera #akomepartners #cns #spanish #italian #akome #uspto #pallàslliberia #christiangriñánferré
Source: Reuters: Health - Category: Consumer Health News Source Type: news